Dihydropyridine Calcium Channel Blocker [EPC]

Dihydropyridine Calcium Channel Blocker [EPC] was reported 328392 times

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

# Drug class Count
0 FATIGUE 19675
1 DIARRHOEA 17906
2 DYSPNOEA 16960
3 NAUSEA 16946
4 DRUG INEFFECTIVE 15737
5 OFF LABEL USE 14736
6 DIZZINESS 13850
7 HEADACHE 13016
8 PAIN 11793
9 ACUTE KIDNEY INJURY 11589
10 VOMITING 11221
11 HYPOTENSION 10592
12 ASTHENIA 10569
13 FALL 10378
14 MALAISE 10257
15 HYPERTENSION 10055
16 ARTHRALGIA 9778
17 DEATH 9741
18 PNEUMONIA 9563
19 COUGH 8022
20 RASH 8020
21 BLOOD PRESSURE INCREASED 7868
22 DRUG INTERACTION 7848
23 PAIN IN EXTREMITY 7741
24 PRURITUS 7713
25 PYREXIA 7668
26 WEIGHT DECREASED 7484
27 TOXICITY TO VARIOUS AGENTS 7412
28 DECREASED APPETITE 7153
29 CONSTIPATION 6618
30 RENAL FAILURE 6617
31 PERIPHERAL SWELLING 6557
32 CHRONIC KIDNEY DISEASE 6405
33 ABDOMINAL PAIN 6106
34 COMPLETED SUICIDE 6102
35 BACK PAIN 6055
36 ANAEMIA 6038
37 CONDITION AGGRAVATED 5977
38 CHEST PAIN 5797
39 OEDEMA PERIPHERAL 5761
40 INSOMNIA 5739
41 ANXIETY 5708
42 CONFUSIONAL STATE 5162
43 JOINT SWELLING 4914
44 URINARY TRACT INFECTION 4883
45 GAIT DISTURBANCE 4882
46 ABDOMINAL PAIN UPPER 4845
47 DEHYDRATION 4717
48 MUSCLE SPASMS 4661
49 MYALGIA 4606
50 FEELING ABNORMAL 4597
51 SOMNOLENCE 4517
52 ABDOMINAL DISCOMFORT 4329
53 WEIGHT INCREASED 4177
54 DEPRESSION 4143
55 RENAL IMPAIRMENT 4137
56 CEREBROVASCULAR ACCIDENT 3981
57 PALPITATIONS 3943
58 INTENTIONAL OVERDOSE 3838
59 COVID-19 3803
60 OVERDOSE 3793
61 ALOPECIA 3778
62 ATRIAL FIBRILLATION 3756
63 MUSCULAR WEAKNESS 3701
64 BLOOD GLUCOSE INCREASED 3656
65 PRODUCT DOSE OMISSION ISSUE 3608
66 NASOPHARYNGITIS 3600
67 HYPONATRAEMIA 3595
68 SYNCOPE 3575
69 HAEMOGLOBIN DECREASED 3544
70 BLOOD CREATININE INCREASED 3477
71 TREMOR 3470
72 BRADYCARDIA 3457
73 MYOCARDIAL INFARCTION 3440
74 PARAESTHESIA 3418
75 PRODUCT USE IN UNAPPROVED INDICATION 3415
76 ERYTHEMA 3378
77 LOSS OF CONSCIOUSNESS 3265
78 HYPOAESTHESIA 3080
79 SEPSIS 3058
80 HEART RATE INCREASED 2996
81 DRUG HYPERSENSITIVITY 2947
82 GENERAL PHYSICAL HEALTH DETERIORATION 2901
83 MEMORY IMPAIRMENT 2868
84 CHEST DISCOMFORT 2848
85 VISION BLURRED 2841
86 HYPOKALAEMIA 2837
87 BALANCE DISORDER 2785
88 HYPERHIDROSIS 2784
89 PLATELET COUNT DECREASED 2768
90 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2733
91 ASTHMA 2713
92 HYPERSENSITIVITY 2636
93 CARDIAC ARREST 2630
94 TACHYCARDIA 2618
95 CONTUSION 2612
96 GASTROINTESTINAL HAEMORRHAGE 2611
97 ABDOMINAL DISTENSION 2609
98 PRODUCT USE ISSUE 2607
99 VISUAL IMPAIRMENT 2582
100 HYPERKALAEMIA 2548
101 DYSPEPSIA 2516
102 METABOLIC ACIDOSIS 2503
103 CARDIAC FAILURE 2502
104 END STAGE RENAL DISEASE 2500
105 BLOOD PRESSURE DECREASED 2496
106 RESPIRATORY FAILURE 2477
107 GASTROOESOPHAGEAL REFLUX DISEASE 2433
108 INFLUENZA 2413
109 DYSPHAGIA 2409
110 ARTHRITIS 2391
111 INFECTION 2379
112 THROMBOCYTOPENIA 2377
113 CHILLS 2327
114 DRY MOUTH 2326
115 INTENTIONAL PRODUCT USE ISSUE 2313
116 URTICARIA 2300
117 PLEURAL EFFUSION 2295
118 OXYGEN SATURATION DECREASED 2274
119 INCORRECT DOSE ADMINISTERED 2255
120 CARDIAC FAILURE CONGESTIVE 2233
121 OEDEMA 2233
122 OROPHARYNGEAL PAIN 2218
123 PULMONARY OEDEMA 2214
124 ANGIOEDEMA 2207
125 EPISTAXIS 2185
126 HALLUCINATION 2169
127 WHITE BLOOD CELL COUNT DECREASED 2141
128 SWELLING 2139
129 SUICIDE ATTEMPT 2132
130 INJECTION SITE PAIN 2126
131 NEUTROPENIA 2124
132 LACTIC ACIDOSIS 2123
133 SHOCK 2111
134 WHEEZING 2088
135 HOSPITALISATION 2072
136 MUSCULOSKELETAL STIFFNESS 2054
137 DRY SKIN 2039
138 FLUSHING 2033
139 NEUROPATHY PERIPHERAL 2033
140 PSORIASIS 2027
141 PULMONARY EMBOLISM 2006
142 DYSPNOEA EXERTIONAL 1973
143 DRUG DOSE OMISSION 1972
144 HYPOGLYCAEMIA 1944
145 DISEASE PROGRESSION 1936
146 SEIZURE 1933
147 SINUSITIS 1920
148 RHEUMATOID ARTHRITIS 1912
149 LETHARGY 1903
150 MALIGNANT NEOPLASM PROGRESSION 1896
151 MOBILITY DECREASED 1882
152 DYSGEUSIA 1875
153 DRUG INTOLERANCE 1865
154 HOT FLUSH 1865
155 DIABETES MELLITUS 1860
156 SWELLING FACE 1823
157 RHABDOMYOLYSIS 1810
158 PRODUCTIVE COUGH 1778
159 RENAL FAILURE ACUTE 1768
160 BLOOD PRESSURE SYSTOLIC INCREASED 1761
161 INTENTIONAL PRODUCT MISUSE 1759
162 FEBRILE NEUTROPENIA 1738
163 HEART RATE DECREASED 1737
164 BRONCHITIS 1719
165 CATARACT 1706
166 FLUID RETENTION 1681
167 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1680
168 HAEMORRHAGE 1660
169 MIGRAINE 1659
170 TINNITUS 1654
171 HYPOXIA 1652
172 ALANINE AMINOTRANSFERASE INCREASED 1645
173 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1636
174 SLEEP DISORDER 1634
175 VERTIGO 1634
176 FOETAL EXPOSURE DURING PREGNANCY 1626
177 GASTROINTESTINAL DISORDER 1615
178 CARDIAC DISORDER 1606
179 RENAL INJURY 1587
180 AMNESIA 1574
181 LIP SWELLING 1568
182 RHINORRHOEA 1568
183 TRANSIENT ISCHAEMIC ATTACK 1566
184 HAEMATOCHEZIA 1561
185 MEDICATION ERROR 1547
186 BLOOD PRESSURE FLUCTUATION 1545
187 ILLNESS 1541
188 CELLULITIS 1523
189 STRESS 1522
190 FLATULENCE 1518
191 RENAL DISORDER 1515
192 COGNITIVE DISORDER 1509
193 INTERSTITIAL LUNG DISEASE 1502
194 HYPERGLYCAEMIA 1489
195 DEPRESSED LEVEL OF CONSCIOUSNESS 1480
196 RECTAL HAEMORRHAGE 1466
197 THROMBOSIS 1463
198 BLISTER 1455
199 SKIN EXFOLIATION 1453
200 DYSPHONIA 1452
201 ASPARTATE AMINOTRANSFERASE INCREASED 1449
202 TUBULOINTERSTITIAL NEPHRITIS 1442
203 ORTHOSTATIC HYPOTENSION 1424
204 NASAL CONGESTION 1419
205 MUSCULOSKELETAL PAIN 1418
206 BURNING SENSATION 1409
207 PRODUCT QUALITY ISSUE 1406
208 SWOLLEN TONGUE 1404
209 OSTEOARTHRITIS 1397
210 PANCYTOPENIA 1391
211 STOMATITIS 1380
212 DISTURBANCE IN ATTENTION 1372
213 NECK PAIN 1371
214 MATERNAL EXPOSURE DURING PREGNANCY 1365
215 POLLAKIURIA 1361
216 RASH PRURITIC 1361
217 ACUTE MYOCARDIAL INFARCTION 1360
218 DEEP VEIN THROMBOSIS 1351
219 ANGINA PECTORIS 1340
220 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1334
221 FEELING HOT 1330
222 PREMATURE BABY 1311
223 EMOTIONAL DISTRESS 1307
224 ARRHYTHMIA 1299
225 DYSARTHRIA 1298
226 AGITATION 1290
227 ELECTROCARDIOGRAM QT PROLONGED 1279
228 HEPATIC ENZYME INCREASED 1275
229 BLOOD POTASSIUM DECREASED 1267
230 ADVERSE DRUG REACTION 1260
231 THERAPY INTERRUPTED 1255
232 INFUSION RELATED REACTION 1247
233 C-REACTIVE PROTEIN INCREASED 1234
234 LOWER RESPIRATORY TRACT INFECTION 1234
235 INFLUENZA LIKE ILLNESS 1226
236 NEPHROGENIC ANAEMIA 1194
237 HERPES ZOSTER 1193
238 SKIN DISCOLOURATION 1159
239 LUNG DISORDER 1155
240 DELIRIUM 1148
241 INFLAMMATION 1147
242 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1147
243 WHITE BLOOD CELL COUNT INCREASED 1140
244 DYSURIA 1139
245 HYPOMAGNESAEMIA 1137
246 TREATMENT NONCOMPLIANCE 1137
247 CARDIO-RESPIRATORY ARREST 1131
248 BONE PAIN 1130
249 PRODUCT DOSE OMISSION 1123
250 DEPRESSED MOOD 1109
251 DISCOMFORT 1105
252 DISORIENTATION 1105
253 CARDIOGENIC SHOCK 1103
254 URINARY RETENTION 1098
255 HAEMATURIA 1096
256 ARTHROPATHY 1091
257 SUICIDAL IDEATION 1075
258 BLINDNESS 1072
259 PANCREATITIS 1071
260 SPEECH DISORDER 1068
261 UNEVALUABLE EVENT 1068
262 BLOOD CHOLESTEROL INCREASED 1067
263 EYE PAIN 1062
264 MENTAL STATUS CHANGES 1043
265 CORONARY ARTERY DISEASE 1039
266 COMA 1038
267 THROAT IRRITATION 1028
268 CEREBRAL HAEMORRHAGE 1024
269 PROTEINURIA 1015
270 HEPATIC FUNCTION ABNORMAL 1013
271 SEPTIC SHOCK 1000
272 ANAPHYLACTIC REACTION 994
273 MULTIPLE ORGAN DYSFUNCTION SYNDROME 989
274 INTERNATIONAL NORMALISED RATIO INCREASED 988
275 OSTEOPOROSIS 985
276 EXPOSURE DURING PREGNANCY 981
277 HYPOCALCAEMIA 981
278 SKIN ULCER 975
279 NERVOUSNESS 973
280 PRODUCT SUBSTITUTION ISSUE 973
281 CEREBRAL INFARCTION 962
282 NEPHROLITHIASIS 952
283 VASCULITIS 951
284 NO ADVERSE EVENT 947
285 CYSTITIS 945
286 ECZEMA 944
287 DIPLOPIA 935
288 ASCITES 931
289 HYPOTHYROIDISM 921
290 THERAPY CESSATION 917
291 URINARY INCONTINENCE 915
292 MELAENA 914
293 BLOOD GLUCOSE DECREASED 911
294 LIVER DISORDER 907
295 CIRCULATORY COLLAPSE 903
296 COLITIS 903
297 RED BLOOD CELL COUNT DECREASED 903
298 BLOOD CREATINE PHOSPHOKINASE INCREASED 888
299 EYE PRURITUS 888
300 GOUT 884
301 RASH ERYTHEMATOUS 883
302 APHASIA 875
303 DISEASE RECURRENCE 870
304 NIGHTMARE 869
305 EYE IRRITATION 862
306 UPPER RESPIRATORY TRACT INFECTION 862
307 SEROTONIN SYNDROME 861
308 BLOOD UREA INCREASED 859
309 HAEMATEMESIS 858
310 RESPIRATORY DISTRESS 858
311 CHOLELITHIASIS 857
312 PNEUMONIA ASPIRATION 857
313 ADVERSE EVENT 856
314 THERAPY NON-RESPONDER 853
315 HEAD INJURY 846
316 ERECTILE DYSFUNCTION 843
317 PAIN IN JAW 841
318 PREMATURE DELIVERY 837
319 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 834
320 SUSPECTED SUICIDE 831
321 ACUTE RESPIRATORY FAILURE 830
322 VENTRICULAR TACHYCARDIA 828
323 LEUKOPENIA 821
324 PULMONARY HYPERTENSION 821
325 HYPERTENSIVE CRISIS 819
326 UPPER GASTROINTESTINAL HAEMORRHAGE 818
327 BLOOD PRESSURE ABNORMAL 817
328 GASTRITIS 815
329 HAEMOPTYSIS 815
330 DRUG-INDUCED LIVER INJURY 808
331 PERICARDIAL EFFUSION 807
332 MUSCLE TWITCHING 802
333 DISTRIBUTIVE SHOCK 800
334 HYPOPHAGIA 798
335 DRY EYE 797
336 INTESTINAL OBSTRUCTION 796
337 NEUTROPHIL COUNT DECREASED 793
338 HAEMATOMA 792
339 FEELING COLD 790
340 UNRESPONSIVE TO STIMULI 790
341 DRUG LEVEL INCREASED 788
342 LIMB DISCOMFORT 788
343 ACCIDENTAL OVERDOSE 783
344 LIVER FUNCTION TEST ABNORMAL 779
345 BLOOD SODIUM DECREASED 774
346 FAECES DISCOLOURED 768
347 HEART RATE IRREGULAR 768
348 DIVERTICULITIS 767
349 FREQUENT BOWEL MOVEMENTS 767
350 DYSSTASIA 765
351 CONTRAINDICATED PRODUCT ADMINISTERED 764
352 RESTLESSNESS 762
353 PANCREATITIS ACUTE 759
354 ALTERED STATE OF CONSCIOUSNESS 754
355 SUBARACHNOID HAEMORRHAGE 753
356 UNDERDOSE 751
357 HIP FRACTURE 749
358 COLITIS ULCERATIVE 746
359 ILL-DEFINED DISORDER 745
360 NIGHT SWEATS 745
361 PRESYNCOPE 744
362 INJECTION SITE ERYTHEMA 742
363 DYSKINESIA 741
364 TASTE DISORDER 739
365 BLOOD ALKALINE PHOSPHATASE INCREASED 735
366 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 733
367 BLOOD POTASSIUM INCREASED 730
368 PNEUMONITIS 727
369 ENCEPHALOPATHY 725
370 HAEMATOCRIT DECREASED 724
371 CROHN^S DISEASE 722
372 EYE SWELLING 720
373 TYPE 2 DIABETES MELLITUS 720
374 ORAL PAIN 719
375 SKIN LESION 719
376 GAMMA-GLUTAMYLTRANSFERASE INCREASED 716
377 LEUKOCYTOSIS 714
378 RASH MACULAR 713
379 TREATMENT FAILURE 713
380 MOVEMENT DISORDER 711
381 PLASMA CELL MYELOMA 710
382 SURGERY 708
383 THERAPEUTIC RESPONSE DECREASED 705
384 GAIT INABILITY 701
385 GLOMERULAR FILTRATION RATE DECREASED 701
386 ANHEDONIA 699
387 PALLOR 698
388 OCULAR HYPERAEMIA 694
389 JAUNDICE 691
390 AGEUSIA 690
391 RESPIRATORY TRACT INFECTION 689
392 DEVICE ISSUE 688
393 PAIN OF SKIN 686
394 NOCTURIA 684
395 HYPOACUSIS 680
396 LYMPHADENOPATHY 677
397 ACUTE RESPIRATORY DISTRESS SYNDROME 674
398 NEURALGIA 674
399 HEMIPARESIS 670
400 HYPERPARATHYROIDISM SECONDARY 669
401 DIABETES MELLITUS INADEQUATE CONTROL 666
402 RASH PAPULAR 664
403 HALLUCINATION, VISUAL 659
404 INJECTION SITE BRUISING 656
405 INJECTION SITE HAEMORRHAGE 656
406 MUCOSAL INFLAMMATION 655
407 CHROMATURIA 651
408 SYSTEMIC LUPUS ERYTHEMATOSUS 650
409 SLEEP APNOEA SYNDROME 648
410 INJURY 645
411 LIMB INJURY 645
412 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 641
413 LOCALISED INFECTION 637
414 EATING DISORDER 630
415 HYPERSOMNIA 629
416 MOUTH ULCERATION 628
417 BASAL CELL CARCINOMA 626
418 NEOPLASM MALIGNANT 626
419 FLUID OVERLOAD 625
420 BLOOD BILIRUBIN INCREASED 624
421 BLOOD PRESSURE INADEQUATELY CONTROLLED 624
422 DEMENTIA 622
423 SINUS BRADYCARDIA 618
424 RASH MACULO-PAPULAR 614
425 PERICARDITIS 612
426 BLOOD URINE PRESENT 610
427 HEPATIC STEATOSIS 609
428 GASTRIC ULCER 607
429 LACRIMATION INCREASED 606
430 CHOLESTASIS 604
431 HAEMORRHOIDS 603
432 GLYCOSYLATED HAEMOGLOBIN INCREASED 600
433 ISCHAEMIC STROKE 600
434 BLOOD PRESSURE DIASTOLIC DECREASED 599
435 MENTAL DISORDER 599
436 IRRITABILITY 598
437 SKIN DISORDER 598
438 VIRAL INFECTION 598
439 FACIAL PAIN 597
440 EOSINOPHILIA 592
441 PRODUCT PRESCRIBING ERROR 592
442 ROAD TRAFFIC ACCIDENT 592
443 BLOOD CALCIUM DECREASED 590
444 DRUG ERUPTION 590
445 SEDATION 589
446 DRUG ABUSE 588
447 RENAL TUBULAR NECROSIS 586
448 OBSTRUCTIVE AIRWAYS DISORDER 585
449 POOR QUALITY SLEEP 585
450 LOW BIRTH WEIGHT BABY 584
451 HYPERCALCAEMIA 583
452 ANOSMIA 581
453 GINGIVAL BLEEDING 580
454 STAPHYLOCOCCAL INFECTION 579
455 RESPIRATORY ARREST 578
456 THERAPEUTIC PRODUCT EFFECT DECREASED 576
457 AGGRESSION 575
458 ACNE 571
459 DIABETIC KETOACIDOSIS 571
460 CONVULSION 570
461 PULMONARY FIBROSIS 570
462 VASOPLEGIA SYNDROME 567
463 JOINT STIFFNESS 563
464 PSORIATIC ARTHROPATHY 562
465 ANURIA 561
466 EYE DISORDER 558
467 WOUND 556
468 RESPIRATORY DISORDER 555
469 SNEEZING 551
470 VISUAL ACUITY REDUCED 548
471 FUNGAL INFECTION 547
472 CLOSTRIDIUM DIFFICILE INFECTION 546
473 CARDIOMEGALY 544
474 BODY TEMPERATURE DECREASED 542
475 FEMUR FRACTURE 542
476 SUBDURAL HAEMATOMA 541
477 HEPATIC FAILURE 540
478 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 540
479 GINGIVAL HYPERTROPHY 536
480 THERAPEUTIC RESPONSE UNEXPECTED 535
481 DEVICE MALFUNCTION 533
482 STEVENS-JOHNSON SYNDROME 531
483 AGRANULOCYTOSIS 530
484 HAIR COLOUR CHANGES 530
485 INJECTION SITE SWELLING 530
486 CAROTID ARTERY OCCLUSION 529
487 GLAUCOMA 527
488 SINUS DISORDER 527
489 IMPAIRED QUALITY OF LIFE 526
490 PRURITUS GENERALISED 526
491 EPILEPSY 525
492 INTERVERTEBRAL DISC PROTRUSION 525
493 NEOPLASM PROGRESSION 525
494 ELECTROLYTE IMBALANCE 524
495 INTENTIONAL DOSE OMISSION 524
496 GASTRIC DISORDER 523
497 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 522
498 IMPAIRED HEALING 522
499 RIB FRACTURE 522
500 HYPERLIPIDAEMIA 521
501 HEPATITIS 520
502 HAEMODYNAMIC INSTABILITY 516
503 FULL BLOOD COUNT DECREASED 515
504 TOXIC EPIDERMAL NECROLYSIS 515
505 MITRAL VALVE INCOMPETENCE 511
506 CORONARY ARTERY OCCLUSION 507
507 DRUG EFFECT DECREASED 506
508 PULMONARY ARTERIAL HYPERTENSION 504
509 PANIC ATTACK 503
510 JOINT INJURY 501
511 MUSCULOSKELETAL CHEST PAIN 500
512 DEAFNESS 499
513 PROSTATE CANCER 497
514 PULMONARY MASS 493
515 COORDINATION ABNORMAL 491
516 GENERALISED OEDEMA 491
517 THIRST 490
518 BLOOD COUNT ABNORMAL 488
519 CHOKING 488
520 LABORATORY TEST ABNORMAL 488
521 BREAST CANCER 486
522 HIATUS HERNIA 486
523 LIVER INJURY 484
524 TENSION HEADACHE 483
525 ATRIOVENTRICULAR BLOCK COMPLETE 479
526 DIALYSIS 479
527 BRONCHIECTASIS 478
528 INJECTION SITE PRURITUS 478
529 LUNG NEOPLASM MALIGNANT 477
530 SKIN BURNING SENSATION 477
531 MICTURITION URGENCY 475
532 GASTROENTERITIS 473
533 KIDNEY INFECTION 473
534 ACCIDENTAL EXPOSURE TO PRODUCT 471
535 MUSCULOSKELETAL DISCOMFORT 471
536 PROSTATIC SPECIFIC ANTIGEN INCREASED 471
537 GINGIVAL PAIN 470
538 MULTIPLE SCLEROSIS RELAPSE 470
539 BLOOD PRESSURE SYSTOLIC ABNORMAL 468
540 MIDDLE INSOMNIA 465
541 SINUS CONGESTION 465
542 SLEEP TERROR 465
543 FEEDING DISORDER 463
544 RASH GENERALISED 463
545 BLOOD LACTATE DEHYDROGENASE INCREASED 462
546 HYPOTHERMIA 462
547 TACHYPNOEA 462
548 TOOTH DISORDER 461
549 RETCHING 460
550 BACTERIAL INFECTION 459
551 CARDIAC MURMUR 458
552 SINUS TACHYCARDIA 455
553 PULMONARY CONGESTION 454
554 URINE OUTPUT DECREASED 454
555 PERIPHERAL COLDNESS 453
556 ABDOMINAL PAIN LOWER 452
557 HEAD DISCOMFORT 451
558 ULCER 450
559 LIVER FUNCTION TEST INCREASED 444
560 ATRIAL TACHYCARDIA 443
561 IMPAIRED GASTRIC EMPTYING 443
562 LOCAL SWELLING 443
563 IMPAIRED WORK ABILITY 442
564 TRANSAMINASES INCREASED 442
565 NEPHROPATHY 441
566 RHINITIS 441
567 PRURITUS GENITAL 440
568 RESPIRATORY TRACT CONGESTION 439
569 ABNORMAL BEHAVIOUR 437
570 BLOOD IRON DECREASED 436
571 BLOOD MAGNESIUM DECREASED 435
572 PEMPHIGOID 434
573 EJECTION FRACTION DECREASED 433
574 THROAT TIGHTNESS 432
575 LYMPHOCYTE COUNT DECREASED 431
576 SEASONAL ALLERGY 429
577 COAGULOPATHY 428
578 SCIATICA 427
579 DERMATITIS ATOPIC 423
580 PRODUCT DOSE OMISSION IN ERROR 422
581 REBOUND ACID HYPERSECRETION 422
582 BODY TEMPERATURE INCREASED 421
583 FULL BLOOD COUNT ABNORMAL 421
584 HAIR TEXTURE ABNORMAL 421
585 BLOOD PRESSURE DIASTOLIC ABNORMAL 419
586 DRUG EFFECT INCOMPLETE 417
587 INJECTION SITE MASS 416
588 MYOCARDIAL ISCHAEMIA 416
589 RALES 414
590 ABASIA 413
591 ABNORMAL DREAMS 413
592 DIZZINESS POSTURAL 413
593 HYPERTHYROIDISM 413
594 PRODUCT ADMINISTRATION ERROR 412
595 HYPOKINESIA 411
596 ERUCTATION 410
597 HEPATOTOXICITY 410
598 PHOTOSENSITIVITY REACTION 408
599 SPUTUM DISCOLOURED 408
600 CARDIOSPASM 407
601 MULTI-ORGAN FAILURE 407
602 NEPHROPATHY TOXIC 407
603 PROCEDURAL PAIN 406
604 DERMATITIS 404
605 ANAPHYLACTIC SHOCK 403
606 BLOOD TRIGLYCERIDES INCREASED 403
607 HEMIPLEGIA 403
608 RED BLOOD CELL SEDIMENTATION RATE INCREASED 403
609 ATRIOVENTRICULAR BLOCK FIRST DEGREE 402
610 NERVOUS SYSTEM DISORDER 402
611 OLIGURIA 402
612 OSTEOMYELITIS 401
613 PALMOPLANTAR KERATODERMA 401
614 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 400
615 WITHDRAWAL SYNDROME 398
616 COLD SWEAT 397
617 GLOSSODYNIA 397
618 TRANSFUSION 397
619 EAR PAIN 394
620 HAEMORRHAGE INTRACRANIAL 393
621 INJECTION SITE REACTION 393
622 PRESCRIBED UNDERDOSE 393
623 MYOPATHY 390
624 OBESITY 390
625 APLASTIC ANAEMIA 389
626 ARTERIOSCLEROSIS 389
627 ORAL HERPES 389
628 UPPER LIMB FRACTURE 387
629 OSTEONECROSIS OF JAW 386
630 ECONOMIC PROBLEM 385
631 SKIN CANCER 385
632 ADRENAL INSUFFICIENCY 383
633 HERNIA 383
634 METASTASES TO LIVER 383
635 PERITONITIS 383
636 UROSEPSIS 383
637 FACE OEDEMA 382
638 LEFT VENTRICULAR HYPERTROPHY 382
639 FEAR 381
640 BRAIN FOG 379
641 VENTRICULAR EXTRASYSTOLES 379
642 ATELECTASIS 378
643 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 378
644 OESOPHAGITIS 377
645 PLATELET COUNT INCREASED 377
646 RENAL CYST 376
647 RESTLESS LEGS SYNDROME 376
648 ARTERIAL OCCLUSIVE DISEASE 375
649 BREATH SOUNDS ABNORMAL 375
650 RENAL FAILURE CHRONIC 375
651 ACIDOSIS 374
652 CARDIOVASCULAR DISORDER 374
653 POST PROCEDURAL COMPLICATION 374
654 ILEUS 372
655 HYPERCHOLESTEROLAEMIA 371
656 BLOOD GLUCOSE ABNORMAL 370
657 NON-CARDIOGENIC PULMONARY OEDEMA 370
658 VENTRICULAR FIBRILLATION 370
659 CLOSTRIDIUM DIFFICILE COLITIS 368
660 COVID-19 PNEUMONIA 367
661 THERAPEUTIC RESPONSE SHORTENED 366
662 IRON DEFICIENCY ANAEMIA 365
663 OSTEOPENIA 364
664 SECRETION DISCHARGE 364
665 MENTAL IMPAIRMENT 363
666 SPINAL FRACTURE 363
667 INCREASED APPETITE 362
668 SMALL INTESTINAL OBSTRUCTION 362
669 EAR INFECTION 361
670 THYROID DISORDER 360
671 BLOOD TEST ABNORMAL 358
672 PNEUMOTHORAX 358
673 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 357
674 SYNOVITIS 357
675 CANDIDA INFECTION 355
676 CREATININE RENAL CLEARANCE DECREASED 355
677 FOOT FRACTURE 355
678 MOOD ALTERED 355
679 MUSCLE SPASTICITY 355
680 CRYING 354
681 CYTOKINE RELEASE SYNDROME 354
682 PHARYNGEAL OEDEMA 354
683 POLYURIA 354
684 ACUTE CORONARY SYNDROME 353
685 KNEE ARTHROPLASTY 353
686 ATRIOVENTRICULAR BLOCK 352
687 PHOTOPHOBIA 352
688 GASTROENTERITIS VIRAL 351
689 HAIR DISORDER 351
690 ANGER 350
691 PARKINSON^S DISEASE 350
692 SKIN HAEMORRHAGE 350
693 HAEMODIALYSIS 348
694 PETECHIAE 347
695 RESPIRATORY RATE INCREASED 347
696 TROPONIN INCREASED 347
697 FIBROMYALGIA 346
698 SPINAL OSTEOARTHRITIS 345
699 BACTERAEMIA 344
700 BODY HEIGHT DECREASED 344
701 MUSCLE TIGHTNESS 344
702 PSYCHOTIC DISORDER 344
703 EXPIRED PRODUCT ADMINISTERED 343
704 CHOLECYSTITIS 342
705 PARAESTHESIA ORAL 342
706 PAROSMIA 341
707 BONE DISORDER 340
708 DISSEMINATED INTRAVASCULAR COAGULATION 340
709 ANKLE FRACTURE 338
710 MADAROSIS 338
711 HEPATIC CIRRHOSIS 337
712 MYOCLONUS 337
713 THROMBOTIC MICROANGIOPATHY 335
714 BLINDNESS UNILATERAL 334
715 MUSCULOSKELETAL DISORDER 334
716 ROTATOR CUFF SYNDROME 334
717 BLOOD LACTIC ACID INCREASED 333
718 DRUG WITHDRAWAL SYNDROME 333
719 MOTOR DYSFUNCTION 333
720 TENDONITIS 332
721 FLANK PAIN 331
722 ORAL CANDIDIASIS 331
723 VAGINAL HAEMORRHAGE 331
724 ATRIAL FLUTTER 330
725 BENIGN PROSTATIC HYPERPLASIA 330
726 DECREASED ACTIVITY 330
727 EMOTIONAL DISORDER 330
728 COLON CANCER 328
729 EXTRA DOSE ADMINISTERED 326
730 FOETAL GROWTH RESTRICTION 326
731 MUSCLE ATROPHY 326
732 NEEDLE ISSUE 326
733 PROTEIN URINE PRESENT 326
734 TOOTHACHE 326
735 NEUROTOXICITY 325
736 NEUTROPHIL COUNT INCREASED 325
737 GENERALISED TONIC-CLONIC SEIZURE 323
738 SPINAL PAIN 323
739 BLOOD ALBUMIN DECREASED 322
740 FEELING JITTERY 322
741 HYPOVOLAEMIA 322
742 EMPHYSEMA 321
743 KIDNEY TRANSPLANT REJECTION 321
744 PRODUCT STORAGE ERROR 321
745 RAYNAUD^S PHENOMENON 321
746 GROIN PAIN 319
747 HYPOPHOSPHATAEMIA 319
748 MAJOR DEPRESSION 319
749 PRODUCT DISPENSING ERROR 318
750 SCAR 318
751 SENSORY DISTURBANCE 318
752 JOINT RANGE OF MOTION DECREASED 317
753 TRICUSPID VALVE INCOMPETENCE 317
754 EXTRAPYRAMIDAL DISORDER 316
755 NEPHROTIC SYNDROME 316
756 EYE HAEMORRHAGE 315
757 SENSORY LOSS 315
758 WRONG TECHNIQUE IN DRUG USAGE PROCESS 315
759 INTERNAL HAEMORRHAGE 314
760 BLOOD URIC ACID INCREASED 313
761 CARDIAC FAILURE ACUTE 313
762 FRACTURE 313
763 HEPATOCELLULAR INJURY 312
764 CARPAL TUNNEL SYNDROME 311
765 ELECTROCARDIOGRAM ABNORMAL 310
766 PHYSICAL DECONDITIONING 310
767 BRASH SYNDROME 308
768 CARDIOMYOPATHY 308
769 DELUSION 308
770 DEVICE RELATED INFECTION 308
771 DRUG DOSE OMISSION BY DEVICE 308
772 BLOOD PRESSURE DIASTOLIC INCREASED 307
773 BONE DENSITY DECREASED 307
774 LUNG INFECTION 306
775 NEUTROPENIC SEPSIS 306
776 SKIN IRRITATION 306
777 DRUG ADMINISTRATION ERROR 303
778 PARKINSONISM 303
779 TOOTH INFECTION 303
780 MASS 302
781 ANAL INCONTINENCE 301
782 ABNORMAL LOSS OF WEIGHT 300
783 ATAXIA 300
784 MULTIPLE SCLEROSIS 300
785 DRUG EXPOSURE DURING PREGNANCY 299
786 CONJUNCTIVITIS 298
787 HOSPICE CARE 298
788 IRRITABLE BOWEL SYNDROME 298
789 MALIGNANT MELANOMA 298
790 PSYCHOLOGICAL TRAUMA 298
791 BACK DISORDER 297
792 MYOSITIS 297
793 APATHY 296
794 APHONIA 296
795 HEPATOMEGALY 293
796 RENAL PAIN 292
797 HYDRONEPHROSIS 291
798 MALNUTRITION 290
799 PNEUMONIA BACTERIAL 290
800 GINGIVAL SWELLING 288
801 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 288
802 SEDATION COMPLICATION 288
803 CYTOMEGALOVIRUS INFECTION 287
804 IMMUNODEFICIENCY 287
805 MOOD SWINGS 287
806 PRE-ECLAMPSIA 287
807 SUPRAVENTRICULAR TACHYCARDIA 287
808 BONE MARROW FAILURE 286
809 BURSITIS 286
810 BRAIN OEDEMA 285
811 ASPIRATION 284
812 INCORRECT PRODUCT ADMINISTRATION DURATION 283
813 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 282
814 CYANOSIS 282
815 GALLBLADDER DISORDER 282
816 ACTIVITIES OF DAILY LIVING IMPAIRED 280
817 HYPERVOLAEMIA 280
818 INFUSION SITE PAIN 280
819 INCONTINENCE 279
820 LARGE INTESTINE POLYP 279
821 MYASTHENIA GRAVIS 279
822 SPLENOMEGALY 279
823 ARTERIOSCLEROSIS CORONARY ARTERY 277
824 BOWEL MOVEMENT IRREGULARITY 276
825 HAEMORRHAGIC STROKE 276
826 NODULE 276
827 SKIN LACERATION 276
828 SQUAMOUS CELL CARCINOMA 276
829 TENDERNESS 276
830 INTESTINAL ISCHAEMIA 275
831 PHARYNGEAL SWELLING 275
832 PRODUCT PHYSICAL ISSUE 275
833 DRUG DEPENDENCE 274
834 LOWER LIMB FRACTURE 274
835 METASTASES TO LUNG 274
836 PURPURA 274
837 GANGRENE 273
838 DRY THROAT 272
839 INTERVERTEBRAL DISC DEGENERATION 272
840 PARALYSIS 272
841 PRODUCT AVAILABILITY ISSUE 272
842 VITAMIN D DECREASED 272
843 ABSCESS 271
844 INCORRECT DRUG ADMINISTRATION DURATION 271
845 ORAL DISCOMFORT 271
846 LOWER GASTROINTESTINAL HAEMORRHAGE 270
847 ACUTE PULMONARY OEDEMA 269
848 COLITIS ISCHAEMIC 269
849 PRESCRIBED OVERDOSE 269
850 AORTIC ANEURYSM 268
851 INCREASED TENDENCY TO BRUISE 268
852 PYELONEPHRITIS 267
853 DIASTOLIC DYSFUNCTION 266
854 DUODENAL ULCER 266
855 LYMPHOPENIA 266
856 UPPER-AIRWAY COUGH SYNDROME 266
857 ANGINA UNSTABLE 264
858 LUNG INFILTRATION 264
859 PHARYNGITIS 264
860 BLOOD PRESSURE SYSTOLIC DECREASED 263
861 HYPOALBUMINAEMIA 263
862 HYPOPNOEA 263
863 WEIGHT FLUCTUATION 263
864 EYELID OEDEMA 262
865 DRUG PRESCRIBING ERROR 261
866 HYPERURICAEMIA 261
867 IMMUNISATION 261
868 METASTASES TO BONE 261
869 SHOCK HAEMORRHAGIC 261
870 CARDIOTOXICITY 260
871 FAECES SOFT 260
872 QUALITY OF LIFE DECREASED 260
873 VITAMIN D DEFICIENCY 260
874 TOXIC SKIN ERUPTION 258
875 SARS-COV-2 TEST POSITIVE 257
876 SKIN FISSURES 257
877 BLOOD CALCIUM INCREASED 256
878 DEVICE DISLOCATION 256
879 DIVERTICULUM 256
880 HYPOAESTHESIA ORAL 256
881 TOOTH LOSS 256
882 HIP ARTHROPLASTY 255
883 POISONING 255
884 LEFT VENTRICULAR DYSFUNCTION 253
885 RENAL FUNCTION TEST ABNORMAL 253
886 CYTOPENIA 252
887 POLYP 251
888 THINKING ABNORMAL 250
889 HYPERKERATOSIS 249
890 BLOOD GLUCOSE FLUCTUATION 245
891 BRONCHOSPASM 245
892 DRUG RESISTANCE 245
893 HALLUCINATION, AUDITORY 245
894 HYPOVOLAEMIC SHOCK 245
895 PANCREATIC CARCINOMA 245
896 PNEUMOCYSTIS JIROVECII PNEUMONIA 245
897 CORONARY ARTERY STENOSIS 244
898 NERVE COMPRESSION 244
899 BEDRIDDEN 243
900 PULMONARY THROMBOSIS 243
901 TENDON RUPTURE 242
902 EAR DISCOMFORT 241
903 MYOCARDITIS 241
904 PRODUCT PRESCRIBING ISSUE 241
905 BLOOD THYROID STIMULATING HORMONE INCREASED 240
906 EXTRASYSTOLES 240
907 HEPATIC CYTOLYSIS 240
908 RENAL CANCER 240
909 IRON DEFICIENCY 239
910 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 239
911 RIGHT VENTRICULAR FAILURE 238
912 TOOTH FRACTURE 237
913 AFFECT LABILITY 236
914 POOR VENOUS ACCESS 236
915 CYST 235
916 JOINT DISLOCATION 234
917 OSTEONECROSIS 234
918 MACULAR DEGENERATION 233
919 POST PROCEDURAL HAEMORRHAGE 233
920 TOOTH ABSCESS 233
921 VITREOUS FLOATERS 233
922 BLADDER CANCER 231
923 DRUG TOXICITY 231
924 POTENTIATING DRUG INTERACTION 231
925 SPINAL COMPRESSION FRACTURE 231
926 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 230
927 EYE INFECTION 230
928 GINGIVITIS 230
929 ISCHAEMIA 230
930 MOUTH HAEMORRHAGE 230
931 POLYNEUROPATHY 228
932 SPRUE-LIKE ENTEROPATHY 228
933 PRODUCT USE COMPLAINT 227
934 INTESTINAL PERFORATION 226
935 POISONING DELIBERATE 226
936 BLOOD CREATINE INCREASED 225
937 BUNDLE BRANCH BLOCK LEFT 225
938 EXERCISE TOLERANCE DECREASED 225
939 PRODUCT TASTE ABNORMAL 225
940 SCAB 225
941 SUDDEN DEATH 224
942 CEREBRAL ISCHAEMIA 221
943 HEPATIC ENCEPHALOPATHY 221
944 WRIST FRACTURE 221
945 BLADDER DISORDER 220
946 CAESAREAN SECTION 220
947 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 220
948 PARANOIA 220
949 PELVIC FRACTURE 220
950 BUNDLE BRANCH BLOCK RIGHT 219
951 LIGAMENT SPRAIN 218
952 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 217
953 GASTROINTESTINAL PAIN 217
954 NERVE INJURY 217
955 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 217
956 SKIN INFECTION 217
957 CAROTID ARTERY STENOSIS 216
958 INFUSION SITE ERYTHEMA 216
959 MUSCLE RIGIDITY 216
960 PULSELESS ELECTRICAL ACTIVITY 216
961 RETINAL DETACHMENT 216
962 CONCOMITANT DISEASE AGGRAVATED 215
963 AORTIC VALVE INCOMPETENCE 214
964 APPLICATION SITE PRURITUS 214
965 ESCHERICHIA INFECTION 214
966 TUMOUR LYSIS SYNDROME 214
967 BREAST PAIN 213
968 DECUBITUS ULCER 213
969 DERMATITIS ALLERGIC 213
970 LYMPHOMA 213
971 ECCHYMOSIS 212
972 GASTRIC HAEMORRHAGE 212
973 PRODUCT ADHESION ISSUE 212
974 PSYCHOMOTOR HYPERACTIVITY 211
975 DIABETIC NEUROPATHY 210
976 INTENTIONAL DRUG MISUSE 210
977 MANIA 210
978 MYELODYSPLASTIC SYNDROME 210
979 ABNORMAL FAECES 209
980 DRUG LEVEL DECREASED 209
981 NEOPLASM 209
982 OCULAR DISCOMFORT 209
983 RESPIRATORY DEPRESSION 209
984 SPINAL OPERATION 209
985 PERITONITIS BACTERIAL 208
986 AORTIC STENOSIS 207
987 EXOSTOSIS 207
988 LEFT VENTRICULAR FAILURE 207
989 TORSADE DE POINTES 207
990 EOSINOPHIL COUNT INCREASED 206
991 FACIAL PARALYSIS 206
992 TARDIVE DYSKINESIA 206
993 WOUND INFECTION 206
994 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 205
995 DIARRHOEA HAEMORRHAGIC 204
996 INTRAOCULAR PRESSURE INCREASED 204
997 PERSONALITY DISORDER 204
998 ANGIOPATHY 203
999 APHTHOUS ULCER 203